September 18th 2024
The FDA has approved the Eversense 365, the world’s first 1-year continuous glucose monitor, with US availability expected in late 2024.
Diabetes and Famine: Some Findings Clinically Applicable
November 23rd 2014Endocrinologists generally see middle-aged people who have developed type 2 diabetes mellitus (T2DM) subsequent to overnutrition (or overeating) and weight gain. Most clinicians tend to forget that low caloric intake, or undernutrition, in the prenatal period or during a child's formative years also seems to increase the risk of the T2DM later in life.
Diabetes & Low T: Treat Testosterone Deficiency?
November 12th 2014Low testosterone is a common condition among men with diabetes-diabetic men are approximately twice as likely as others to develop low testosterone and hypogonadism. Because its symptoms mimic other conditions, patients often fail to report concerns and clinicians may fail to diagnose "Low T."
Less Medication, Better Glycemic Control Seen in Low Saturated Fat Diet for Type 2 Diabetes
November 9th 2014For individuals with type 2 diabetes mellitus, a low carbohydrate, low saturated fat diet in combination with exercise resulted in superior glycemic control with less medication use than did a higher carbohydrate diet
Algorithms Not Sole Factor in Prescribing for Obese Patients
November 6th 2014There is currently no algorithm to guide clinicians in deciding which medication to choose to help promote weight loss in individuals with obesity. Rather, clinicians must take stock of a variety of factors when making treatment decisions for a particular patient.
New Device Beats Placebo, Produces Durable Results in Moderately Obese Patients
November 6th 2014An intragastric dual-balloon device was well tolerated and proved effective for patients with moderate levels of obesity, owing in part to its ability to conform to stomach anatomy, according to Jaime Ponce, MD, Medical Director for the Bariatric Surgery program at Hamilton Medical Center, in Dalton, Georgia.